guaifenesin + pseudoephedrine hydrochloride: clinical use

Prescribing considerations

• Confirm that symptoms include both productive cough and upper-airway congestion.
• Check for duplicate cough-and-cold products, sympathomimetics and clinically important antidepressant interactions.
• Seek medical review for persistent or recurrent cough, fever, rash, persistent headache, haemoptysis, excessive secretions or suspected chronic respiratory disease.
• Use caution in moderate-to-severe renal impairment, severe hepatic impairment, urinary difficulty, prostatic enlargement, asthma, chronic bronchitis or emphysema.

Contraindications and cautions

• Hypersensitivity to either active ingredient or an excipient.
• Cardiovascular disease, including hypertension; beta-blocker treatment.
• Other sympathomimetic decongestants.
• Diabetes mellitus, closed-angle glaucoma, hyperthyroidism or phaeochromocytoma.
• Current or recent monoamine oxidase inhibitor use.
• Severe acute or chronic kidney disease or renal failure.
• Children under 12 years.

Monitoring

• Assess blood pressure and cardiovascular risk before recommending pseudoephedrine-containing treatment.
• Advise patients to stop treatment and seek urgent assessment for PRES or RCVS symptoms, sudden visual loss, ischaemic colitis symptoms or severe skin reactions.
• Consider urinary retention, palpitations, agitation, insomnia and worsening hypertension if adverse effects develop.
• Guaifenesin metabolites may interfere with urinary 5-HIAA and VMA testing.

Clinical pharmacology

Pseudoephedrine has direct and indirect sympathomimetic activity, causing vasoconstriction in congested upper-airway mucosa. Guaifenesin is thought to increase the volume and reduce the viscosity of respiratory secretions. Pseudoephedrine is mainly eliminated in urine, and its half-life may be substantially prolonged by renal impairment; guaifenesin undergoes oxidation and demethylation.

Formulation and product differences

• The selected formulation is a clear orange-red oral syrup supplied with a measuring spoon.
• It contains sucrose, ethanol, benzyl alcohol, methyl and propyl hydroxybenzoates, Ponceau 4R and Sunset Yellow. These excipients may matter in allergy, sugar intolerance, pregnancy, breastfeeding, or liver and kidney impairment.
• The selected product page is marked discontinued on eMC, so availability and the formulation of alternatives should be checked rather than assumed equivalent.